Study: Protein blocker eases smoking-related lung inflammation in mice

03/18/2010 | Yahoo!

Mice showed a reduction in lung inflammation caused by exposure to cigarette smoke after they were treated with an agent that blocks the activity of a protein called granulocyte macrophage-colony stimulating factor, Australian scientists found. They said the finding might lead to additional ways of treating chronic pulmonary obstructive disease and other conditions related to smoking.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT